Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Rob-Chemist who wrote (615)	1/13/1998 6:31:00 PM
From: Tech Investor	Read Replies (1) \| Respond to of 3576

Here is a few tips on shorting: no matter how stupid the news is, NEVER short a stock when it has plenty of steam of left. You will just get yourself killed in the process. Take NANX for example, the day it ran for 5+ points, on 1 lousy upgrade from their underwriter (ha!) and Joe Kernan's mention. Investors are not rational, market is inefficient, not every buyer is a chemist or bio-chemist. As long as the news look good, they will buy in. To short GERN at this level is stupidity IMO. Wait for the news to hit most of the wires, and tv, newspapers before shorting. I'm long at this moment, but I will short when the momentum turns, so far I have no idea when it is turning (sometime in the coming week I think). BTW, I heard 20/20 is gonna do a report on GERN. Best of luck to your shorts Regards

To: Rob-Chemist who wrote (615)	1/13/1998 8:19:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 3576

>> However, there is no evidence that telomere shortening is involved in aging of normal human cells and/or humans. Even in very old people, they have plenty of telomere left. Furthermore, even if telomere shortening were important for aging (and adding telomerase back to these cells could reverse the aging process), this finding is completely irrelevant in terms of Geron having a product. << Well, seems there is evidence that adding telomerase gene results in lengthening of telomeres and greatly extended cell life. So your statement above even if correct, may not be relevant. Nor is it completely irrelevant in terms of having a product. Rather it is the first of many steps. I do agree it will be many years to a product. >> the University of Texas Southwestern Medical Center at Dallas reported today the successful extension of the life-span of normal human cells using the enzyme telomerase. In a paper published in the journal Science, January 16, 1998, scientists explain that the introduction of an active telomerase gene into normal mortal cells resulted in the lengthening of telomeres and a marked increase in the life-span of the cells, making the cells potentially immortal. <<